|Bid||0.4500 x 1000|
|Ask||0.4700 x 900|
|Day's Range||0.4400 - 0.5120|
|52 Week Range||0.4400 - 1.8600|
|Beta (5Y Monthly)||1.45|
|PE Ratio (TTM)||1.88|
|Earnings Date||Nov 05, 2020 - Nov 09, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.38|
During Q2, Genesis Healthcare's (NYSE: GEN) reported sales totaled $956.26 million. Despite a 2902.37% in earnings, the company posted a loss of $230.58 million. Genesis Healthcare collected $1.09 billion in revenue during Q1, but reported earnings showed a $7.68 million loss.What Is Return On Capital Employed? Changes in earnings and sales indicate shifts in Genesis Healthcare's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q2, Genesis Healthcare posted an ROCE of 0.22%.It is important to keep in mind ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but several factors could affect earnings and sales in the near future.View more earnings on GENReturn on Capital Employed is an important measurement of efficiency and a useful tool when comparing companies that operate in the same industry. A relatively high ROCE indicates a company may be generating profits that can be reinvested into more capital, leading to higher returns and growing EPS for shareholders.For Genesis Healthcare, the return on capital employed ratio shows the number of assets can actually help the company achieve higher returns, an important note investors will take into account when gauging the payoff from long-term financing strategies.Q2 Earnings Insight Genesis Healthcare reported Q2 earnings per share at $-0.2/share, which did not meet analyst predictions of $-0.03/share.See more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * 12 Healthcare Stocks Moving In Wednesday's Pre-Market Session * 12 Healthcare Stocks Moving In Tuesday's After-Market Session(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
KENNETT SQUARE, Pa., Oct. 13, 2020 (GLOBE NEWSWIRE) -- LTC ACO, the first long-term care sponsored Accountable Care Organization (“ACO”) in the United States and a subsidiary of Genesis HealthCare (Genesis) (NYSE:GEN), recently received a positive reconciliation and settlement under the Medicare Shared Savings Program (“MSSP”) for the 2019 performance year and as a result, generated shared savings for the second consecutive year.During 2019, the Company managed approximately 5,800 Medicare fee-for-service beneficiaries under the MSSP with annualized Medicare spend of more than $160 million. In 2019, the MSSP required the LTC ACO to save at least 2.8% of the total Medicare spend under management to share in up to 62.5% (50% applicable to the first half of the year and 75% for the second) of the savings with Centers for Medicare and Medicaid Services (CMS). In August 2020, CMS notified Genesis that it reached the minimum savings rate set by CMS required for gain share. As a result, in the third quarter of 2020, the LTC ACO will recognize MSSP shared savings of approximately $18.8 million and income of approximately $17.0 million net of participating provider distributions.“With more than four years of participation under the MSSP, we have gained valuable experience driving better outcomes and improved quality, managing episodic cost and developing in-house capabilities to predict program performance,” notes Jason Feuerman, President of LTC ACO. “In fact, we generated an approximate 19.6% savings rate on costs under management and a 94.5% quality score in the 2019 MSSP performance year. These scores and quality outcomes reflect the benefits of our collaboration with dedicated Genesis Physician Services (GPS) physicians and advance practice providers as well as improved alignment and collaboration with other participating physicians, creating an environment to achieve these goals. This alignment is something that has rarely been accomplished heretofore in the long-term care industry.”Now contracted with more than 200 non-Genesis affiliated long-term care facilities and physicians nationally, LTC ACO is well positioned to improve quality and create a newly aligned shared savings revenue opportunity for both those serving long-term care residents.Going forward, LTC ACO plans to continue to bring its expertise to non-Genesis long-term care facilities and clinical providers over the coming year. Participation in the LTC ACO can be significantly expanded more broadly throughout the long-term care industry due to its track record of positive patient outcomes as well as positive financial results.ABOUT LTC ACOLTC ACO is a Medicare Shared Savings Program (MSSP) Accountable Care Organization (ACO) for Medicare Beneficiaries who reside in long-term care (LTC) facilities. The ACO’s participating physicians and clinicians work hard to provide better, more coordinated care to the Medicare Beneficiaries they treat in the LTC facilities. Medicare Beneficiaries continue to receive all benefits covered by Original Medicare, from any Medicare provider of their choice, and their benefits are not limited because the physician is a part of the ACO. Visit our website at https://www.ltcaco.com/.Contact: Lori Mayer Media Relations 610-283-4995
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.The following stocks are considered to be notable value stocks in the healthcare sector: 1. Onconova Therapeutics (NASDAQ: ONTX) - P/E: 0.85 2. Genesis Healthcare (NYSE: GEN) - P/E: 1.5 3. Coherus BioSciences (NASDAQ: CHRS) - P/E: 7.13 4. Seneca Biopharma (NASDAQ: SNCA) - P/E: 9.82 5. Five Star Senior Living (NASDAQ: FVE) - P/E: 3.65Onconova Therapeutics has reported Q2 earnings per share at -0.04, which has decreased by 33.33% compared to Q1, which was -0.03. Onconova Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.Genesis Healthcare has reported Q2 earnings per share at -0.2, which has decreased by 171.43% compared to Q1, which was 0.28. Genesis Healthcare does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.Coherus BioSciences has reported Q2 earnings per share at 0.81, which has increased by 68.75% compared to Q1, which was 0.48. Coherus BioSciences does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.Seneca Biopharma has reported Q2 earnings per share at -0.15, which has increased by 37.5% compared to Q1, which was -0.24. Seneca Biopharma does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.Most recently, Five Star Senior Living reported earnings per share at 0.1, whereas in Q1 earnings per share sat at -0.55. Five Star Senior Living does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.See more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * 5 Value Stocks To Watch In The Real Estate Sector * 12 Energy Stocks Moving In Monday's Pre-Market Session(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.